Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyHematologic NeoplasmsAntigens, CD34Blood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeGraft SurvivalLymphoma, Non-HodgkinBone Marrow TransplantationHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisImmunosuppressionStem CellsCytarabineHematopoiesisHodgkin DiseaseDisease-Free SurvivalCord Blood Stem Cell TransplantationTransplantation ChimeraRetrospective StudiesTissue DonorsNeoplasmsSurvival RateImmunosuppressive AgentsWhole-Body IrradiationInfectionTime FactorsSurvival AnalysisLymphoma, T-CellDoxorubicinHistocompatibilityPOEMS SyndromePlatelet CountPrednisoneHistocompatibility TestingCarboplatinTransplantation, IsogeneicLeukemia, Myeloid, AcuteDexamethasoneVidarabineFollow-Up StudiesBlood Cell CountRecombinant ProteinsLeukemiaCytomegalovirus InfectionsAntineoplastic AgentsBone Marrow PurgingLymphomaProspective StudiesBlood CellsFatal OutcomeGraft vs Leukemia EffectFeasibility StudiesLiver TransplantationAnemia, AplasticMyelodysplastic SyndromesCyclosporineImmunophenotypingT-LymphocytesLymphocyte DepletionBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveOpportunistic InfectionsLeukocytes, MononuclearHistiocytosis, Non-Langerhans-CellLivedo ReticularisHematologic DiseasesKidney TransplantationHLA AntigensBone MarrowPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisBlood DonorsBreast NeoplasmsMesenchymal Stem Cell Transplantation